Para, M. F., Meehan, P., Holden-Wiltse, J., Fischl, M., Morse, G., Shafer, R., . . . Freimuth, W. W. (1999). ACTG 260: A Randomized, Phase I-II, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy. Antimicrob Agents Chemother.
Chicago Style CitationPara, Michael F., et al. "ACTG 260: A Randomized, Phase I-II, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy." Antimicrob Agents Chemother 1999.
Cita MLAPara, Michael F., et al. "ACTG 260: A Randomized, Phase I-II, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy." Antimicrob Agents Chemother 1999.
Atenció: Aquestes cites poden no estar 100% correctes.